
New Drug Nearly Doubles Pancreatic Cancer Survival Time
A breakthrough medication targeting a previously "undruggable" genetic mutation could transform treatment for one of the deadliest cancers. Patients in late-stage trials lived nearly twice as long when taking the new drug alongside chemotherapy.




